chitosan has been researched along with Leishmaniasis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Croft, SL; Loiseau, PM; Pomel, S | 1 |
| Bera, T; Das, S; De, AK; Ghosh, S | 1 |
| Akhtar, S; Ashraf, S; Hussain, I; Hussain, SZ; Rafay, M; Sarwar, HS; Shahnaz, G; Sohail, MF; Yasinzai, M | 1 |
| Badiee, A; Chavoshian, O; Hojatizade, M; Jaafari, MR; Soleymani, M; Tafaghodi, M | 1 |
| Asgari, Q; Esfandiari, F; Heli, H; Molaei, M; Morowvat, MH; Motazedian, MH | 1 |
| Bou-Chacra, N; Cotrim, PC; de Araújo, GLB; Fotaki, N; Löbenberg, R; Monteiro, LM | 1 |
| Abánades, DR; Andrade, PH; Arruda, LV; Castilho, RO; Chávez-Fumagalli, MA; Coelho, EA; Costa, LE; Duarte, MC; Faraco, AA; França, JR; Lage, DP; Lage, PS; Martins, VT; Ribeiro, TG; Rodrigues, LB; Tavares, CA; Valadares, DG | 1 |
| Ajdary, S; Alimohammadian, MH; Bahrami, F; Darabi, H; Javadian, S; Khaze, V; Rafiee, A; Riazi-Rad, F | 1 |
| Cardoso, VN; Castilho, RO; Chávez-Fumagalli, MA; Coelho, EA; Costa, LE; Duarte, MC; Faraco, AA; Fernandes, SO; Franca, JR; Fuscaldi, LL; Lage, PS; Martins, VT; Ribeiro, TG; Santos, ML; Soto, M; Tavares, CA | 1 |
| Dube, A; Dwivedi, P; Jaiswal, AK; Khatik, R; Mishra, PR; Shukla, P; Tripathi, P | 1 |
1 review(s) available for chitosan and Leishmaniasis
| Article | Year |
|---|---|
Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Betulinic Acid; Biocompatible Materials; Chitosan; Curcumin; Drug Carriers; Drug Compounding; Humans; Hydrogen-Ion Concentration; Leishmaniasis; Leishmaniasis Vaccines; Macrophages; Nanoparticles; Paromomycin; Pentacyclic Triterpenes; Polymers; Rifampin; Selenium; Thiomalates; Titanium; Triterpenes; Ursolic Acid | 2020 |
9 other study(ies) available for chitosan and Leishmaniasis
| Article | Year |
|---|---|
Oral delivery of ursolic acid-loaded nanostructured lipid carrier coated with chitosan oligosaccharides: Development, characterization, in vitro and in vivo assessment for the therapy of leishmaniasis.
Topics: Administration, Oral; Animals; Chitosan; Drug Carriers; Drug Design; Drug Liberation; Female; Leishmaniasis; Lipids; Macrophages; Male; Mice; Mice, Inbred BALB C; Nanostructures; Oligosaccharides; Triterpenes; Ursolic Acid | 2017 |
Mannosylated thiolated polyethylenimine nanoparticles for the enhanced efficacy of antimonial drug against Leishmaniasis.
Topics: Antiprotozoal Agents; Biological Transport; Chitosan; Drug Carriers; Drug Liberation; Humans; Leishmania; Leishmaniasis; Mannose; Meglumine; Meglumine Antimoniate; Nanoparticles; Organometallic Compounds; Particle Size; Polyethyleneimine; Sulfhydryl Compounds; Surface Properties | 2018 |
Chitosan Nanoparticles Loaded with Whole and Soluble Leishmania Antigens, and Evaluation of Their Immunogenecity in a Mouse Model of Leishmaniasis.
Topics: Animals; Antibodies, Protozoan; Antigens, Protozoan; Cells, Cultured; Chitosan; Disease Models, Animal; Female; Humans; Interferon-gamma; Interleukin-4; Leishmania; Leishmaniasis; Leishmaniasis Vaccines; Mice; Mice, Inbred BALB C; Nanoparticles; Th1 Cells; Th1-Th2 Balance; Th2 Cells; Vaccination | 2018 |
Paromomycin-loaded mannosylated chitosan nanoparticles: Synthesis, characterization and targeted drug delivery against leishmaniasis.
Topics: Animals; Chitosan; Drug Delivery Systems; Leishmaniasis; Nanoparticles; Paromomycin; Spectroscopy, Fourier Transform Infrared | 2019 |
Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment.
Topics: Anti-Bacterial Agents; Biopolymers; Chitosan; Dextrans; Drug Combinations; Drug Delivery Systems; Leishmania infantum; Leishmaniasis; Lipids; Nanostructures; Naphthoquinones; Particle Size; Polymyxin B; Thermogravimetry | 2019 |
Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system.
Topics: Amphotericin B; Animals; Chemistry, Pharmaceutical; Chitosan; Chondroitin Sulfates; Drug Delivery Systems; Female; Humans; Leishmania infantum; Leishmania mexicana; Leishmaniasis; Macrophages; Mice; Mice, Inbred BALB C; Nanomedicine; Nanoparticles; Trypanocidal Agents | 2014 |
Ferroportin-encapsulated nanoparticles reduce infection and improve immunity in mice infected with Leishmania major.
Topics: Alginates; Anemia; Animals; Cation Transport Proteins; Chitosan; Cytokines; Female; Glucuronic Acid; Hematocrit; Hexuronic Acids; Iron; Leishmania major; Leishmaniasis; Lymph Nodes; Mice, Inbred BALB C; Nanoparticles; Parasite Load | 2014 |
An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Chitosan; Chondroitin Sulfates; Female; Kidney; Leishmania; Leishmaniasis; Mice; Mice, Inbred BALB C; Nanoparticles; Tissue Distribution | 2014 |
Development of 4-sulfated N-acetyl galactosamine anchored chitosan nanoparticles: A dual strategy for effective management of Leishmaniasis.
Topics: Acetylgalactosamine; Amphotericin B; Animals; Cell Line; Chitosan; Chromatography, High Pressure Liquid; Leishmaniasis; Macrophages; Mice; Microscopy, Electron, Transmission; Nanoparticles; Spectroscopy, Fourier Transform Infrared; Sulfates | 2015 |